etoposide has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (7.69) | 29.6817 |
2010's | 11 (84.62) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Kapoor, R; Rastogi, N; Sarma, S; Thakkar, D; Wadhwa, T; Yadav, SP | 1 |
Escherich, G; Hagel, C; Hartz, B; Löbel, U | 1 |
Guglin, M; Haq, M; Patel, A | 1 |
Miri-Aliabad, G | 1 |
Ju, X; Li, D; Lu, Y; Sun, N; Zhuang, Y | 1 |
Frey, NV; Ganetsky, A; Landsburg, DJ; Loren, AW; Luger, SM; Luskin, MR; Nasta, SD; Porter, DL; Svoboda, J | 1 |
Davies, C; Hall, AG; Hogarth, LA; Lock, RB; Mackenzie, KL | 1 |
Brown, AW; McGregor, BA; Osswald, MB; Savona, MR | 1 |
Cai, Y; Ling, JY; Sun, XF; Xia, Y; Yan, SL; Zhen, ZJ | 1 |
Commander, LA; Insogna, IG; Rheingold, SR; Seif, AE | 1 |
Chen, X; Lei, P; Li, Y; Liu, L; Zhai, Y; Zhang, Y | 1 |
Hawley, RG; Hawley, TS; Riz, I; Toma, I; Zweier-Renn, LA | 1 |
Bachmann, PS; Davies, C; Dietrich, PA; Hall, AG; Hogarth, LA; Lock, RB; Mackenzie, KL | 1 |
1 review(s) available for etoposide and Leukemia, Lymphoblastic, Acute, T Cell
Article | Year |
---|---|
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
Topics: Adenine Nucleotides; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Etoposide; Fatal Outcome; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Male; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction; Reoperation; Salvage Therapy; Vidarabine; Vincristine; Young Adult | 2009 |
1 trial(s) available for etoposide and Leukemia, Lymphoblastic, Acute, T Cell
Article | Year |
---|---|
Salvage therapy with nelarabine, etoposide, and cyclophosphamide in relapsed/refractory paediatric T-cell lymphoblastic leukaemia and lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Child; Child, Preschool; Cyclophosphamide; Etoposide; Female; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Humans; Male; Nervous System Diseases; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction; Salvage Therapy; Treatment Outcome; Young Adult | 2010 |
11 other study(ies) available for etoposide and Leukemia, Lymphoblastic, Acute, T Cell
Article | Year |
---|---|
COVID-19 reinfection in two children with cancer.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Carboplatin; Child, Preschool; Cisplatin; COVID-19; Cyclophosphamide; Daunorubicin; Etoposide; Humans; Male; Neuroblastoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Reinfection; SARS-CoV-2; Vincristine | 2021 |
Fatal neurological side-effects with necrosis of spinal cord following nelarabine treatment in a child with relapsed T-cell acute lymphoblastic leukemia.
Topics: Antimetabolites, Antineoplastic; Arabinonucleosides; Cerebellum; Child; Cyclophosphamide; Cytarabine; Etoposide; Fatal Outcome; Guillain-Barre Syndrome; Humans; Magnetic Resonance Imaging; Male; Medulla Oblongata; Methotrexate; Necrosis; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Recurrence; Seizures; Spinal Cord | 2013 |
Cardiac lymphoma: sinus pauses disappear after chemotherapy.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Atrial Fibrillation; Cisplatin; Cytarabine; Etoposide; Female; Humans; Methylprednisolone; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Sick Sinus Syndrome | 2014 |
Green urine secondary to methylene blue.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Child; Diagnosis, Differential; Etoposide; Humans; Ifosfamide; Male; Methylene Blue; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Urine | 2014 |
Upregulation of AIOLOS induces apoptosis and enhances etoposide chemosensitivity in Jurkat leukemia cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Differentiation; Cell Line, Tumor; Cyclin D3; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Drug Resistance, Neoplasm; Etoposide; G1 Phase Cell Cycle Checkpoints; Humans; Ikaros Transcription Factor; Jurkat Cells; Lentivirus; NF-kappa B; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; S-Phase Kinase-Associated Proteins; T-Lymphocytes; Up-Regulation | 2015 |
Nelarabine, cyclosphosphamide and etoposide for adults with relapsed T-cell acute lymphoblastic leukaemia and lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Cyclophosphamide; Etoposide; Female; Humans; Lymphoma; Male; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Salvage Therapy | 2016 |
p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; B-Lymphocytes; Caspase 3; Caspase 7; Cell Cycle Checkpoints; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Gene Expression Regulation, Leukemic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Masoprocol; Phosphatidylserines; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; RNA, Small Interfering; Signal Transduction; Sp1 Transcription Factor; T-Lymphocytes; Transcription, Genetic; Tumor Suppressor Protein p53; Vorinostat | 2015 |
Significance of myeloid antigen expression in precursor T lymphoblastic lymphoma.
Topics: Adolescent; Adult; Age Factors; Aged; Antigens, CD7; Antigens, Differentiation, Myelomonocytic; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Cyclin D3; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Etoposide; Female; Follow-Up Studies; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Proportional Hazards Models; Remission Induction; Survival Rate; Transcription Factors; Vincristine; Young Adult | 2010 |
Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Chromosomes, Human, Pair 13; Chromosomes, Human, Pair 8; Cyclophosphamide; Dexamethasone; Doxorubicin; Etoposide; Humans; Male; Myeloproliferative Disorders; Phenotype; Precancerous Conditions; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Syndrome; Translocation, Genetic; Vincristine | 2010 |
Apoptotic role of IKK in T-ALL therapeutic response.
Topics: Apoptosis; Boronic Acids; Bortezomib; Drug Resistance, Neoplasm; Etoposide; Gene Expression Regulation, Neoplastic; Humans; I-kappa B Kinase; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-myc; Pyrazines; Receptor, Notch1; Signal Transduction; Vincristine | 2011 |
p53-independent epigenetic repression of the p21(WAF1) gene in T-cell acute lymphoblastic leukemia.
Topics: Acetylation; Adolescent; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Child; Child, Preschool; CpG Islands; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; DNA Methylation; Epigenesis, Genetic; Etoposide; Female; Gene Expression Profiling; Gene Expression Regulation, Leukemic; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Jurkat Cells; Male; Mice; Mice, SCID; Neoplasm Transplantation; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Transplantation, Heterologous; Tumor Suppressor Protein p53; Vorinostat | 2011 |